TTC-352 [1607819-68-0]

MedChem Express

TTC-352 [1607819-68-0]

5

1607819-68-0

Research Use Only

C20H13FO3S

352.38

TTC-352 is an orally bioavailable selective human estrogen receptor (ER) alpha partial agonist (ShERPA). TTC-352 inhibits the growth of three ER+ breast cancer cells. TTC-352 induces tumor regression accompanied by exit of ERalpha from the nucleus to extranuclear sites[1][2].

OC1=CC=C(C(C2=CC=C(F)C=C2)=C(OC3=CC=C(O)C=C3)S4)C4=C1

12352200